🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with surmount-osa: tirzepatide and sleep apnea ahi reduction? Page 4

Has anyone dealt with surmount-osa: tirzepatide and sleep apnea ahi reduction?

TinaHashiRN Sat, Apr 26, 2025 at 12:17 PM 23 replies 1,672 viewsPage 4 of 5
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Apr 30, 2025 at 12:19 PM#16

Clinical perspective, offered as context rather than as advice. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

I would rather be corrected than agreed with, if it comes to it.

20 20DebRD_ATL, KristenIndy, MarkLI_maint and 17 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Apr 30, 2025 at 7:53 PM#17
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

19 19emily_PDX, Dr.SleepRoch, laura_annarbor and 16 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
May 1, 2025 at 3:27 AM#18

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

I would rather be corrected than agreed with, if it comes to it.

18 18RunnerRach, TrialNerd_Beth, HPLC_Greg and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
May 1, 2025 at 11:00 AM#19
JenPlateau said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Mine went the same way, slower. Posting only so the count is not one.

Last edited: May 1, 2025 at 2:00 PM
17 17TinaHashiRN, robert_kc, dan_philly and 14 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 1, 2025 at 6:33 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Report rather than reply if it drifts again.

45 20PurityPaulOR, MaxMetOK, MounjBrad and 42 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register